The five-member ring heterocyclic compounds, which are core components of a large number of substances that possess a wide range of interesting biological activities. 1 In this respect, the potential of the pyrazole scaffold to serve as a privileged structure for the generation of drug-like libraries in drug-discovery programs has been amply demonstrated. The recent success of a pyrazole COX-II (cyclooxygenase) inhibitor has further highlighted the importance of these heterocycles in medicinal chemistry. 2 In addition, the pyrimidinedione and pyrimidinethione ring systems found in quinazolinediones and quinazolinethiones have been used as drug pharmacophores.
3 By using the bioisostere concept, we have designed scaffolds that combine the pyrimidinethione moiety found in quinazolinethiones with the pyrazole ring system. The pyrazolo[1,5-a][1,3,5]thioxotriazine bicyclic system, coming from this formulation, is present in substances that are known inhibitors of protein kinase CK2 (casein kinase), 4 phosphodiesterase (PDE4), 5 and DNA gyrase. 6 Another driving force for this combined drug discovery and high throughput organic synthesis program, focusing on drug-like small heterocyclic molecules, 7 is the development of novel modulators of protein kinase CK2 and PDE4 that participate in the control of inflammatory diseases. Since these types of modulators possess pyrazolo[1,5-a][1,3,5]triazine functionality, one of the purposes of this effort was the development of a new types of scaffolds, such as the pyrazolo[1,5-a][1,3,5]-2-oxo-4thioxotriazine, that might be found in protein kinase inhibitors.
Several reports exist describing the efficient solution-phase synthesis of pyrazolo[1,5-a][1,3,5]triazine derivatives that possess drug-like properties. 8 However, methods to readily generate pyrazolo[1,5-a][1,3,5]thioxotriazines by employing solidphase synthesis have not been reported. As a result, we under took an investigation aimed at developing efficient and simple parallel solid-phase synthetic methods to produce various druglike pyrazolo[1,5-a][1,3,5]thioxotriazine derivatives. We previously reported an efficient procedure for the synthesis of a novel 7,8-functionalized pyrazolo[1,5-a][1,3,5]-2-oxo-4-thioxotriazine derivatives. 9 From the previously reported method could be limited only pyrazolo[1,5-a][1,3,5]-2,4-dithioxotriazine on solid-phase. We needed to come up with an pyrazolo-[1,5-a][1,3,5]-2,4-dithioxotriazine for the application of extended library using resin-bound 3,4-functionalized-5-amino-1-dithiocarboxy-pyrazoles 3 and 4 by the reaction of various isothiocyanates.
Here in, we describe the development of an efficient procedure for the synthesis of a novel 7,8-functionalized-pyrazolo-[1,5-a][1,3,5]-2,4-dithioxotriazine derivatives 5 and 6 (Scheme 1) through solid phase cyclization reactions of resin-bound 3,4functionalized-5-amino-1-dithiocarboxy-pyrazoles 3 and 4 with various thiocyanates.
The Merrifield resin 1 was selected as the polymer support used in this investigation. The reaction of this resin 1 with carbon disulfide followed by treatment with hydrazine monohydrate leads to formation of the resin bound dithiocarbazate 2. We have developed more convenient synthetic rote to the resin 2 compared to the previous report 9 by treatment of hydrazine monohydrate and carbondisulfide with potassium hydroxide in ethanol solvent. In this reaction condition, we could obtain the resin 2 without Fmoc-protection step of hydrazine. Reactions of 2 with cyanocarboimidates 7 and 3-ethoxyacrylonitriles 8 gave to the respective polymer-bound 5-amino-1-dithiocarboxy pyrazole resins 3 and 4. 7c Finally, the desired taregt 7,8-functionalized pyrazolo[1,5-a][1,3,5]-2,4-dithioxotriazine derivatives 5 and 6 were liberated from the respective 5-aminopyrazole resins 3 and 4 through the formation of pyrazole thiourea intermediate resin with various aryl isothiocyanates and follows out the intra molecular cyclization reaction.
Notes
The progress of all of the solid phase reactions employed in these sequences was monitored by using ATR-FTIR spectroscopy on single beads (Supporting Information S6, S7). For example, the formation of the dithiocarbazate resin 2 was demonstrated by the generation of prominent carbamate bands at 1361 cm -1 by ATR-FTIR. And the pyrazole resin 3 could obtain from the dithiocarbazate resin 2 by treated with cyanocarboimidates 7 in acetonitrile. The progress of this reaction was monitored by the appearance of the cyanonitrile stretching band at 2217 cm -1 .
On the other hand, the cyclization reactions of hydrazine dithiocarbazate resin 2 with substituted-3-ethoxyacrylonitriles 8 proceeded well in 1,4-dioxane solvent, as indicated by the appearance of the ester stretching band of resin bound 5-amino pyrazole 4 at 1685 cm -1 .
The concurrent cyclization-resin cleavage reactions of 5amino pyrazole resins 3 and 4 were progressed in the presence of Et3N (THF, 40 o C, 12 h) same as concurrent clization reaction conditions with isocyanates. 9 In the case of reactions of the 4ethylcarboxy-5-amino pyrazole resins 4, the strong base NaH is required (THF, 40 o C, 12 h) to proceed the first nucleophilc reaction of pyrazole amino group to isothiocyanates. As shown in Table 1 and 2, we could obtain various 7,8-functionalizedpyrazolo[1,5-a][1,3,5]-2,4-dithioxotriazine derivatives 5 and 6 by the concurrent reaction of 5-amino pyrazole resins 3 and 4 with aryl isothiocyanates in good three step overall yields starting from the Merrifield resin with high purities.
In conclusion, the results of the investigation described above demonstrate that 7,8-functionalized pyrazolo[1,5-a][1,3,5]-2,4dithioxotriazine derivatives 5 and 6 can be efficiently prepared by using a concise solid phase synthetic sequence involving the intermediacy of the 5-amino-1-dithiocarboxypyrazole resins 3 and 4. Cyclization reactions of pyrazole resins 3 and 4, promoted by treatment with various substituted aryl isothiocyanates results in liberation from the resins of the respective target 7,8functionalized-pyrazolo[1,5-a][1,3,5]-2,4-dithioxotriazines derivatives 5 and 6 in high overall yields and high purities.
Experimental Procedures
General. All chemicals were reagent grade and used as purchased. The Merrifield resin (loading capacity 2.00 mmol/g, 100 ~ 200 mesh) was purchased from BeadTech. Reactions were monitored by TLC analysis using Merck silica gel 60 F-254 thin layer plates or ATR-FRIR analysis using TravelIR TM (SensIR Technology). Flash column chromatography was carried out on Merck silica gel 60 (230 ~ 400 mesh). On solid-phase synthesis, reactions, filteration, and washing were carried out on a Mini-Block (Bohdan) and solvent evaporation was performed on a GeneVac Atlas HT-4 centrifugal vacuum evaporator. The crude products were purified by parallel chromatography using Quad-3 TM . 1 H NMR and 13 C NMR spectra were recorded in d units relative to deuterated solvent as internal reference by Bruker 500 MHz NMR instrument. LC-MS analysis was performed on ESI mass spectrometer with PDA detection. LC-MS area% purities of all products were determined by LC peak area analysis (XTerraMS C18 column, 4.6 mm × 100 mm; PDA detector at 200 ~ 400 nm; gradient, 5 ~ 95% CH3CN//H2O).
Preparation of dithiocarbazate resin (2). To suspension of hydrazine mono-hydrate (10.0 mL, 203.15 mmol) in ethanol (100 mL) at 0 o C was added successively carbon disulfide (13.0 mL, 223.46 mmol) with potassium hydroxide (13.5 g, 243.78 mmol) and the mixture was stirred for 1 h. The reaction mixture was formed two layers with light-brown color and then the lightbrown layer was dissolved in DMF (150 mL) at 0 o C. And then Merrifield resin 1 (30.0 g, loading capacity 2.0 mmol/g) was added to the previous light-brown DMF solution. The mixture was stirred at rt for 4 h. The resin was filtered, washed several times with CH2Cl2, DMF, H2O and MeOH and dried in a vacuum oven to give dithiocarbazate resin 2 (5.72 g) as an light yellow solid. On-bead ATR-FTIR (cm -1 ) 3024, 2919, 1600, 1509, 1492, 1450, 1421, 1363, 1180, 1154, 1028, 838, 755, 744, 697. Preparation of 5-amino-1-dithiocarbamoyl pyrazole resin (3a). To a suspension of dithiocarbazate resin 2 (5.0 g, theoretically 10.0 mmol) in acetonitrile (70 mL) at rt was added 2-(1ethoxyethylidene)malononitrile (4.1 g, 30.0 mmol) and Et3N (4.18 mL, 30.0 mmol). The mixture was stirred at rt for 17 h. The resin was filtered, washed several times with DMF, MeOH, CH 2 Cl 2 and MeOH, and dried in a vacuum oven. The 5-amino-1-dithiocarbamoyl pyrazole resin 3a was obtained as a yellow (5.6 g). On-bead ATR-FTIR (cm -1 ) 3024, 2919 3024, , 2215 3024, (CN), 1619 3024, , 1602 3024, , 1562 3024, , 1509 3024, , 1492 3024, , 1451 3024, , 1390 3024, , 1357 3024, , 1318 3024, , 1153 3024, , 1029 Preparation of 7-methyl-3-phenyl-2,4-dithioxo-1,2,3,4-tetrahydro-pyrazolo[1,5-a][1,3 ,5]triazine-8-carbonitrile (5a). To a mixture of 5-amino-1-dithiocarbamoyl pyrazole resin 3a (300.0 mg, theoretically 0.60 mmol) in DMF (2.0 mL) was added K2CO3 (415.0 mg, 3.00 mmol) and phenyl isothiocyanate (342 µL, 1.80 mmol). and the mixture was stirred at 40 o C for 12 h. The resin was filtered and washed with CH2Cl2, EtOAc. 4 N HCl (2.0 mL) were added; the filtrate was extracted with EtOAc. The residue was purified by a silica gel column chromatography (10 : 1 mixture of ethyl acetate and n-hexane ethyl acetate) to afford the desired product 7-methyl-3-phenyl-2,4-dithioxo-1,2,3,4-tetrahydro-pyrazolo[1,5-a] [1, 3, 5] . Preparation of 5-amino-1-dithiocarbamoyl pyrazole resin (4a). To a suspension of dithiocarbazate resin 2 (5.0 g, theoretically 10.0 mmol) in dioxane (70 mL) at rt was added ethyl (ethoxymethylene)cyanoacetate (5.0 g, 30.0 mmol) and Et3N (4.15 mL, 30.0 mmol). The mixture was stirred at 80 o C for 17 h. The resin was filtered, washed several times with DMF, MeOH, CH2Cl2 and MeOH, and dried in a vacuum oven. The 5-amino-1-dithiocarbamoyl pyrazole resin 4a was obtained as a yellow solid (5.84 g). On-bead ATR-FTIR (cm -1 ) 3409, 3288 (NH2), 3024, 2920, 1679 (C=O), 1612, 1546, 1509, 1492, 1451, 1423, 1329, 1265, 1232, 1153, 1111, 1066, 1018, 964, 873, 839, 757, 737, 697. Preparation of 3-phenyl-2,4-dithioxo-1,2,3,4-tetrahydro-pyrazolo[1,5-a][1,3,5]triazine-8-carboxylic acid ethyl ester (6a) . To a mixture of 5-amino-1-dithiocarbamoyl pyrazole resin 4a (300 mg, theoretically 0.60 mmol) in THF (3.0 mL) at rt was added 60% dispersion of NaH in mineral oil (72.0 mg, 1.80 mmol) and phenyl isothiocyanate (342 µL, 1.80 mmol), and the mixture was stirred at 60 o C for 12 h. The resin was filtered and washed with CH2Cl2, EtOAc. 4 N HCl (2.0 mL) were added; the filtrate was extracted with EtOAc. The residue was purified by a silica gel column chromatography (2:1 mixture of ethyl acetate and n-hexane ethyl acetate) to afford the desired product 3-phenyl-2,4-dithioxo-1,2,3,4-tetrahydro-pyrazolo[1,5-a][1, 3,5]triazine-8-carboxylic acid ethyl ester 6a (105 mg, 53%; 98% purity). 1 
